0001808805-22-000075.txt : 20220628
0001808805-22-000075.hdr.sgml : 20220628
20220628181738
ACCESSION NUMBER: 0001808805-22-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mowry Anna
CENTRAL INDEX KEY: 0001856938
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 221051321
MAIL ADDRESS:
STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC.
STREET 2: 201 INDUSTRIAL RD. #310
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
wf-form4_165645463634483.xml
FORM 4
X0306
4
2022-06-27
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001856938
Mowry Anna
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVENUE EAST
SEATTLE
WA
98102
0
1
0
0
CFO and Treasurer
Common Stock
2022-06-27
4
P
0
5500
2.7499
A
39250
D
Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
/s/ Matthew B. Murphy, as Attorney-in-Fact
2022-06-28